ltrasound-guided non-targeted liver biopsies: complication rates of single versus multiple pass techniques in patients requiring non-targeted liver biopsies.

Dr Luke A Danaher0 个研究点目标入组 296 人开始时间: 2010年2月2日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•All patients presenting to the Royal Brisbane & Women's Hospital (RBWH) Department of Medical Imaging (DMI) who need ultrasound-guided, non-targeted liver biopsies. The study group will not include children as it is an adult hospital. The groups will be randomised to include equal numbers of men and women.

•All patients will be getting biopsies based on a clinical indication. They will have various medical comorbidities. It is an all-comers trial to ensure the results are clinically relevant. Patients won't be included/excluded on their physical fitness. They will simply be included if they need a non-targeted liver biopsy for any reason. Patients with International Normalised Ratio (INR) over 1.5 may be excluded for safety as they are at increased risk of bleeding (current practice). This will be at the discretion of the interventional radiologist performing the biopsy.

发起方

Dr Luke A Danaher